Compugen Ev To Free Cash Flow vs Free Cash Flow Yield Analysis

CGEN Stock

USD 1.59 0.02 1.24%

Compugen financial indicator trend analysis is way more than just evaluating Compugen prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Compugen is a good investment. Please check the relationship between Compugen Ev To Free Cash Flow and its Free Cash Flow Yield accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Ev To Free Cash Flow vs Free Cash Flow Yield

Ev To Free Cash Flow vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Compugen Ev To Free Cash Flow account and Free Cash Flow Yield. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Compugen's Ev To Free Cash Flow and Free Cash Flow Yield is -0.61. Overlapping area represents the amount of variation of Ev To Free Cash Flow that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Compugen, assuming nothing else is changed. The correlation between historical values of Compugen's Ev To Free Cash Flow and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Free Cash Flow of Compugen are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Ev To Free Cash Flow i.e., Compugen's Ev To Free Cash Flow and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

-0.61

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Compugen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Compugen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.As of the 30th of November 2024, Tax Provision is likely to grow to about 9.4 M, while Selling General Administrative is likely to drop about 6.6 M.

	2021	2022	2023	2024 (projected)
Net Interest Income	871K	1.7M	3.2M	3.4M
Interest Income	894K	1.7M	3.0M	3.1M

Net Interest Income Interest Income

Compugen fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Liab	Current Deferred Revenue	Other Assets	Short Term Investments
Total Assets		0.61	0.54	0.95	0.34	-0.03	-0.63	0.44	0.05	0.42	-0.08	0.9	0.24	0.7	0.79	0.18	-0.71	0.8	0.36	0.42	0.9	0.79	-0.2	0.06	0.66	0.63
Other Current Liab	0.61		0.89	0.48	0.25	0.41	-0.89	0.61	-0.34	-0.14	0.16	0.53	0.61	0.92	0.77	0.57	-0.78	0.75	0.75	0.66	0.82	0.77	-0.17	0.41	0.95	0.66
Total Current Liabilities	0.54	0.89		0.37	0.07	0.31	-0.79	0.55	-0.23	0.03	0.17	0.32	0.85	0.86	0.58	0.81	-0.61	0.56	0.94	0.71	0.78	0.58	-0.11	0.69	0.89	0.35
Total Stockholder Equity	0.95	0.48	0.37		0.44	-0.13	-0.5	0.34	0.16	0.53	-0.14	0.94	0.07	0.58	0.67	-0.04	-0.64	0.7	0.16	0.35	0.84	0.66	-0.3	-0.14	0.53	0.61
Property Plant And Equipment Net	0.34	0.25	0.07	0.44		-0.42	-0.33	0.32	0.45	0.07	-0.3	0.43	-0.07	0.3	0.36	-0.28	-0.06	0.41	-0.13	0.64	0.32	0.36	-0.52	-0.5	0.23	0.29
Net Debt	-0.03	0.41	0.31	-0.13	-0.42		-0.27	0.14	-0.99	-0.44	0.59	-0.01	0.22	0.28	0.24	0.34	-0.65	0.14	0.34	-0.09	0.14	0.21	0.08	0.38	0.43	0.49
Retained Earnings	-0.63	-0.89	-0.79	-0.5	-0.33	-0.27		-0.51	0.21	-0.02	-0.24	-0.54	-0.5	-0.98	-0.89	-0.52	0.68	-0.89	-0.68	-0.64	-0.76	-0.89	0.1	-0.3	-0.95	-0.6
Accounts Payable	0.44	0.61	0.55	0.34	0.32	0.14	-0.51		-0.14	0.0	0.08	0.34	0.25	0.47	0.54	0.12	-0.4	0.54	0.33	0.44	0.44	0.52	-0.34	0.06	0.54	0.36
Cash	0.05	-0.34	-0.23	0.16	0.45	-0.99	0.21	-0.14		0.46	-0.59	0.03	-0.14	-0.2	-0.22	-0.26	0.61	-0.12	-0.26	0.17	-0.07	-0.19	-0.09	-0.32	-0.35	-0.47
Non Current Assets Total	0.42	-0.14	0.03	0.53	0.07	-0.44	-0.02	0.0	0.46		0.07	0.28	-0.02	0.1	0.07	-0.16	0.05	0.13	-0.08	0.03	0.22	0.09	-0.32	-0.11	-0.02	-0.11
Non Currrent Assets Other	-0.08	0.16	0.17	-0.14	-0.3	0.59	-0.24	0.08	-0.59	0.07		-0.13	0.05	0.21	0.18	0.17	-0.29	0.14	0.18	-0.1	-0.06	0.18	-0.01	0.18	0.28	0.36
Cash And Short Term Investments	0.9	0.53	0.32	0.94	0.43	-0.01	-0.54	0.34	0.03	0.28	-0.13		-0.08	0.58	0.72	-0.07	-0.72	0.74	0.11	0.23	0.81	0.72	-0.09	-0.21	0.56	0.77
Net Receivables	0.24	0.61	0.85	0.07	-0.07	0.22	-0.5	0.25	-0.14	-0.02	0.05	-0.08		0.6	0.22	0.89	-0.29	0.19	0.92	0.72	0.52	0.21	-0.14	0.85	0.61	-0.05
Common Stock Total Equity	0.7	0.92	0.86	0.58	0.3	0.28	-0.98	0.47	-0.2	0.1	0.21	0.58	0.6		0.84	0.6	-0.74	0.84	0.76	0.69	0.85	0.85	-0.13	0.4	0.97	0.6
Common Stock Shares Outstanding	0.79	0.77	0.58	0.67	0.36	0.24	-0.89	0.54	-0.22	0.07	0.18	0.72	0.22	0.84		0.23	-0.73	0.99	0.42	0.45	0.74	1.0	-0.15	0.04	0.82	0.73
Non Current Liabilities Total	0.18	0.57	0.81	-0.04	-0.28	0.34	-0.52	0.12	-0.26	-0.16	0.17	-0.07	0.89	0.6	0.23		-0.34	0.2	0.96	0.49	0.46	0.25	0.3	0.93	0.62	0.02
Inventory	-0.71	-0.78	-0.61	-0.64	-0.06	-0.65	0.68	-0.4	0.61	0.05	-0.29	-0.72	-0.29	-0.74	-0.73	-0.34		-0.69	-0.49	-0.28	-0.8	-0.72	0.07	-0.25	-0.81	-0.86
Other Stockholder Equity	0.8	0.75	0.56	0.7	0.41	0.14	-0.89	0.54	-0.12	0.13	0.14	0.74	0.19	0.84	0.99	0.2	-0.69		0.39	0.47	0.74	0.99	-0.15	0.0	0.8	0.71
Total Liab	0.36	0.75	0.94	0.16	-0.13	0.34	-0.68	0.33	-0.26	-0.08	0.18	0.11	0.92	0.76	0.42	0.96	-0.49	0.39		0.62	0.64	0.42	0.11	0.86	0.78	0.18
Property Plant And Equipment Gross	0.42	0.66	0.71	0.35	0.64	-0.09	-0.64	0.44	0.17	0.03	-0.1	0.23	0.72	0.69	0.45	0.49	-0.28	0.47	0.62		0.61	0.44	-0.49	0.3	0.64	0.19
Total Current Assets	0.9	0.82	0.78	0.84	0.32	0.14	-0.76	0.44	-0.07	0.22	-0.06	0.81	0.52	0.85	0.74	0.46	-0.8	0.74	0.64	0.61		0.74	-0.15	0.32	0.84	0.64
Common Stock	0.79	0.77	0.58	0.66	0.36	0.21	-0.89	0.52	-0.19	0.09	0.18	0.72	0.21	0.85	1.0	0.25	-0.72	0.99	0.42	0.44	0.74		-0.1	0.04	0.82	0.73
Other Liab	-0.2	-0.17	-0.11	-0.3	-0.52	0.08	0.1	-0.34	-0.09	-0.32	-0.01	-0.09	-0.14	-0.13	-0.15	0.3	0.07	-0.15	0.11	-0.49	-0.15	-0.1		0.27	-0.1	-0.09
Current Deferred Revenue	0.06	0.41	0.69	-0.14	-0.5	0.38	-0.3	0.06	-0.32	-0.11	0.18	-0.21	0.85	0.4	0.04	0.93	-0.25	0.0	0.86	0.3	0.32	0.04	0.27		0.43	-0.12
Other Assets	0.66	0.95	0.89	0.53	0.23	0.43	-0.95	0.54	-0.35	-0.02	0.28	0.56	0.61	0.97	0.82	0.62	-0.81	0.8	0.78	0.64	0.84	0.82	-0.1	0.43		0.66
Short Term Investments	0.63	0.66	0.35	0.61	0.29	0.49	-0.6	0.36	-0.47	-0.11	0.36	0.77	-0.05	0.6	0.73	0.02	-0.86	0.71	0.18	0.19	0.64	0.73	-0.09	-0.12	0.66

Click cells to compare fundamentals

Compugen Account Relationship Matchups

Compugen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.8M	138.3M	132.2M	94.2M	121.3M	70.8M
Other Current Liab	4.4M	7.8M	10.9M	8.9M	11.0M	11.5M
Total Current Liabilities	6.8M	10.5M	17.1M	11.9M	26.3M	27.6M
Total Stockholder Equity	38.3M	119.8M	106.7M	77.7M	65.6M	57.7M
Property Plant And Equipment Net	5.6M	4.5M	3.9M	3.4M	2.5M	3.3M
Net Debt	(40.3M)	(4.0M)	(5.1M)	(9.1M)	(12.5M)	(13.2M)
Retained Earnings	(358.2M)	(387.9M)	(422.1M)	(455.8M)	(474.5M)	(450.8M)
Accounts Payable	1.1M	1.4M	4.6M	1.8M	3.5M	1.9M
Cash	43.9M	7.1M	7.8M	11.1M	13.9M	26.5M
Non Current Assets Total	8.8M	9.2M	8.9M	8.1M	6.8M	10.6M
Non Currrent Assets Other	3.2M	4.7M	5.0M	4.7M	4.2M	3.9M
Cash And Short Term Investments	43.9M	124.4M	117.8M	83.7M	50.7M	48.3M
Net Receivables	1.1M	2.2M	188K	317K	61.3M	64.4M
Common Stock Shares Outstanding	63.6M	79.6M	84.2M	86.6M	87.6M	47.3M
Liabilities And Stockholders Equity	53.8M	138.3M	132.2M	94.2M	121.3M	70.8M
Non Current Liabilities Total	8.6M	8.0M	8.4M	4.6M	29.5M	31.0M
Inventory	(780K)	(119.3M)	(110.0M)	(72.6M)	(65.4M)	(62.1M)
Other Stockholder Equity	396.3M	507.4M	528.5M	533.2M	539.8M	292.4M
Total Liab	15.4M	18.5M	25.5M	16.5M	55.8M	58.6M
Property Plant And Equipment Gross	5.6M	4.5M	3.9M	3.4M	7.9M	8.3M
Total Current Assets	45M	129.1M	123.2M	86.1M	114.6M	120.3M
Accumulated Other Comprehensive Income	(6.3M)	(4.9M)	(5.4M)	2K	2.3K	2.4K
Common Stock	187K	231K	239K	240K	247K	133.4K
Other Liab	5.6M	5.5M	6.4M	3.3M	3.8M	4.6M
Other Assets	3.2M	4.7M	5.0M	4.7M	5.4M	5.7M
Short Term Investments	34.0M	116.6M	109.2M	72.3M	36.8M	29.0M
Other Current Assets	780K	2.5M	5.3M	2.1M	2.6M	4.9M
Property Plant Equipment	5.6M	4.5M	3.9M	3.4M	3.9M	3.4M
Net Tangible Assets	38.3M	119.8M	106.7M	77.7M	89.3M	77.0M
Net Invested Capital	38.3M	119.8M	106.7M	77.7M	65.6M	74.6M
Net Working Capital	38.2M	118.6M	106.1M	74.2M	88.3M	76.5M
Capital Stock	187K	231K	239K	240K	247K	239.8K

Pair Trading with Compugen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Compugen Stock

0.84	ME	23Andme Holding Upward Rally	Pair Corr
0.86	VALN	Valneva SE ADR	Pair Corr

Moving against Compugen Stock

0.74	VCYT	Veracyte	Pair Corr
0.67	VERA	Vera Therapeutics	Pair Corr
0.66	DRUG	Bright Minds Biosciences Trending	Pair Corr
0.45	VANI	Vivani Medical	Pair Corr
0.45	VCEL	Vericel Corp Ord	Pair Corr

The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.

The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:

How To Invest In Compugen

Details

Is Compugen Stock a good investment?

Details

What is Compugen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

0.03

Revenue Per Share

0.48

Quarterly Revenue Growth

3.461

Return On Assets

(0.03)

Return On Equity

(0.16)

The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Compugen Ev To Free Cash Flow vs Free Cash Flow Yield Analysis

Ev To Free Cash Flow vs Free Cash Flow Yield

Ev To Free Cash Flow vs Free Cash Flow Yield Correlation Analysis

Correlation Coefficient

Ev To Free Cash Flow

Free Cash Flow Yield

Compugen fundamental ratios Correlations

Compugen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Compugen fundamental ratios Accounts

Pair Trading with Compugen

Moving together with Compugen Stock

Moving against Compugen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Shares Outstanding
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Other Stockholder Equity
Other Assets	+ 0.97	Common Stock Total Equity
Total Liab	+ 0.96	Non Current Liabilities Total
Total Stockholder Equity	+ 0.95	Total Assets

Cash	- 0.99	Net Debt
Common Stock Total Equity	- 0.98	Retained Earnings
Other Assets	- 0.95	Retained Earnings
Common Stock	- 0.89	Retained Earnings
Other Stockholder Equity	- 0.89	Retained Earnings
Common Stock Shares Outstanding	- 0.89	Retained Earnings